Selecting antithrombotic therapy for patients with atrial fibrillation.
Cleve Clin J Med
; 82(1): 49-63, 2015 Jan.
Article
em En
| MEDLINE
| ID: mdl-25552627
ABSTRACT
When considering anticoagulant therapy for patients with atrial fibrillation, one must balance the reduction in risk of thromboembolism that this therapy offers against the risk of bleeding that it poses. The American Heart Association, American College of Cardiology, and Heart Rhythm Society updated their atrial fibrillation guidelines in 2014. This review outlines a rationale for clinical decision-making based on the new guidelines and summarizes the currently approved drugs.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrilação Atrial
/
Fibrinolíticos
Tipo de estudo:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Cleve Clin J Med
Assunto da revista:
MEDICINA
Ano de publicação:
2015
Tipo de documento:
Article